U.K. authorizes Pfizer vaccine

The U.K. has become the first country to grant Pfizer emergency use of its coronavirus vaccine. Its first 800,000 doses will arrive in just a few days. CBS News foreign correspondent Charlie D'Agata reports.

• Dec 2, 2020
• 01:38

U.K. regulators approve Pfizer vaccine

The U.K. has become the first country in the world to approve Pfizer's coronavirus vaccine for distribution. U.K. officials said they'll be ready to start administering the vaccine as early as next week. CBS News foreign correspondent Charlie D'Agata joined "CBSN AM" to explain how the U.K. was able to move ahead without the European Union and what happens to the AstraZeneca vaccine being tested by Oxford.

• Dec 2, 2020
• 07:29

CDC panel on COVID vaccine distribution

A CDC panel recommended on Tuesday that health care workers and nursing home residents should be first to receive the coronavirus vaccine. Those initial doses from Pfizer and Moderna, which have not yet been FDA approved, could be distributed in two weeks. CBS News correspondents Mola Lenghi and David Begnaud have the latest details, and Dr. Uzma Syed, an infectious disease specialist, joins CBSN's Elaine Quijano to discuss what she will be looking at once the vaccines are out in the public.

• Dec 1, 2020
• 12:59

California warns of "drastic actions" amid pandemic

California Governor Gavin Newsom is warning of "drastic actions" to curb a growing surge surge in new coronavirus infections. Hospitalizations have increased by 89% in two weeks. Jeremy B. White, co-writer of Politico's California Playbook, joins CBSN's Elaine Quijano with the latest on local efforts to combat the spread.

• Dec 1, 2020
• 07:09

Pence says vaccine distribution could begin by mid-December

"We strongly believe the vaccine distribution process could begin as soon as the week of December 14," Pence said.

• Dec 1, 2020

COVID-19 vaccines could roll out in two weeks

CBS News has obtained a document from Operation Warp Speed that estimates December 15 as the date for states to potentially start receiving the Pfizer vaccine with the Moderna vaccine available a week later. The goal is for at least 20 million Americans to start a vaccine regimen by the end of the year. Dr. David Agus joins "CBS This Morning" with more on the distribution timeline.

• Dec 1, 2020
• 02:49

What to expect when COVID vaccine rolls out

The first coronavirus vaccines from Pfizer and Moderna could become available by mid-December. Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University Medical Center, joins CBSN to discuss the impact the vaccine’s release will have on the surging number of cases nationwide.

• Dec 1, 2020
• 04:56

Doctor says herd immunity still long way off

The first doses of a coronavirus vaccine could be distributed as early as mid-December, as hospitals struggle to cope with a growing surge in patients with COVID-19. CBS News correspondent David Begnaud reports on the toll the pandemic is taking on frontline workers, and Dr. Dyan Hes, founder of Gramercy Pediatrics, joined CBSN to discuss which groups should be prioritized when vaccines are distributed, and how long it might take to reach herd immunity.

• Dec 1, 2020
• 08:01

CDC to recommend vaccine distribution plan

The Centers for Disease Control and Prevention is set to meet today to recommend who will be first in line to get the coronavirus vaccine. This comes as hospitalizations in the U.S. continue to skyrocket, surpassing 96,000. CBS News' Debra Alfarone joined "CBSN AM" with more.

• Dec 1, 2020
• 03:31

Inside look at how coronavirus vaccines will be distributed

"This is going to be one of the most challenging public health distribution efforts we've seen," said Dr. Amesh Adalja.

• Dec 1, 2020

Companies prepare for COVID vaccine distribution

CBS News has confirmed that United Airlines is using chartered flights to distribute Pfizer's upcoming coronavirus vaccine. The FDA will consider emergency use approval in December. Kris Van Cleave takes a closer look.

• Nov 30, 2020
• 02:39

Worries about COVID spike after Thanksgiving

Health officials are warning the coronavirus pandemic will continue to get worse as the U.S. is seeing a surge in cases pushing hospitals to the limit in many parts of the country. CBS News' Debra Alfarone joins CBSN AM with the latest on that plus the potential COVID-19 vaccine timeline.

• Nov 30, 2020
• 04:18

COVID-19 vaccine breakthroughs: What happens now?

The latest promising advances in coronavirus vaccines are now posing more questions – about the logistics required to safely transport an approved vaccine, who will get it, and how to combat vaccine skepticism

• Nov 30, 2020

Doctor warns of false sense of COVID security

Millions stuck with their Thanksgiving plans despite a warning from the Centers for Disease Control and Prevention for travelers to just stay home because of the coronavirus pandemic. More than 2,200 COVID-related deaths were reported in the U.S. on the day before Thanksgiving, the highest one-day toll in more than six months. CBS News correspondent Adriana Diaz reports from Chicago, and Dr. Shoshana Ungerleider, an internal medicine physician at California Pacific Medical Center, joined CBSN to discuss.

• Nov 26, 2020
• 08:42

CDC weighs shortening COVID-19 quarantine period

As coronavirus cases in the U.S. spike to record highs, the Centers for Disease Control and Prevention are considering a change to the agency's recommendation about quarantining for 14 days after a person tests positive for coronavirus. Dr. Wilbur Chen-- a professor at the University of Maryland School of Medicine, the director of the UMB Travel Medicine Practice and the chief of adult clinical studies at the Center for Vaccine Development and Global Health -- joins CBSN to discuss the latest developments for a possible coronavirus vaccine and the CDC's approach to vaccine guidelines.

• Nov 25, 2020
• 10:10

U.S. reports 2,100 COVID-19 deaths in one day

More than 2,100 COVID-19 deaths were reported in the U.S. on Tuesday, making it the deadliest day the country has seen in six months. The virus continues to hit hard in America's heartland. "CBS This Morning" lead national correspondent David Begnaud reports from Fargo, North Dakota, and Dr. Leo Nissola, an immunotherapy researcher, joined CBSN to discuss the latest on a vaccine.

• Nov 25, 2020
• 13:15

Doctor explains effectiveness of COVID vaccine

AstraZeneca announced Monday that its COVID-19 vaccine is up to 90% effective and even shows signs of reducing asymptomatic spread. It's effectiveness varied during clinical trials, depending on the dosage, but still averaged 70%. Dr. Uzma Syed, an infection disease specialist at New York's Good Samaritan Hospital Medical Center and director of Antimicrobial Stewardship Center of Excellence, joins CBSN's Elaine Quijano to discuss if the variation in effectiveness is something people should be concerned about.

• Nov 23, 2020
• 07:46

Hospital prepares for COVID-19 vaccine distribution

CBS News got rare access inside Jackson Memorial Hospital in Miami that will be among the first to receive Pfizer's coronavirus vaccine. Mireya Villarreal shows us how health care workers are preparing for its distribution.

• Nov 23, 2020
• 02:06

COVID-19 cases climbing ahead of Thanksgiving

The Thanksgiving travel rush is underway as coronavirus infections are skyrocketing across the country. CBS News' Bofta Yimam joins CBSN AM with more.

• Nov 23, 2020
• 05:45

Pfizer seeks approval of COVID vaccine

A record 87,000 Americans tested positive for the coronavirus on Thursday, and more than 250,000 American have died since the pandemic began. On Friday, Pfizer applied for emergency authorization for its coronavirus vaccine, which could go into distribution by the end of the year. Dr. John Moore. professor of microbiology and immunology at Weill Cornell Medical College at Cornell University, joined CBSN to discuss the latest.

• Nov 20, 2020
• 10:03

COVID-19 vaccine distribution faces challenges

CBS News got an inside look at the logistical challenges of getting Pfizer's coronavirus vaccine to the public, including a required storage temperature you'd find in the coldest places on Earth. Dana Jacobson continues our series "Racing to a Cure."

• Nov 20, 2020
• 02:07

Pfizer submits vaccine for emergency use authorization

On Friday, pharmaceutical company Pfizer became the first company to submit a coronavirus vaccine to the U.S. Food and Drug Administration for an emergency use authorization. Dr. James Phillips, Chief of Disaster Medicine at George Washington University Hospital, walks CBSN through what the approval process entails.

• Nov 20, 2020
• 08:14

How Pfizer will keep its vaccine at -94 degrees during transport

CBS News got an inside look at the logistical challenges of getting Pfizer's COVID-19 vaccine to the public.

• Nov 21, 2020

Pfizer asks U.S. regulators to OK emergency use of COVID vaccine

With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.

• Nov 20, 2020

Doctor responds to COVID task force

The White House coronavirus task force held its first public briefing in months, as the country continues to break its new daily record for COVID-19 cases. CBS News correspondent David Begnaud reports, and Dr. Bob Lahita, chairman of medicine at St. Joseph University Hospital, joined CBSN to discuss new guidelines from public health officials, and what precautions need to be taken ahead of the Thanksgiving holiday.

• Nov 20, 2020
• 09:48

Show More